PROF · Transaction Jul 21, 2020 · Filed Mar 5, 2021 · $1,001 to $15,000
Profound Medical Corp
Veridion Score
BETALOW CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PROF moving today?
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PROF overview
Related filings and maps
Congress activity in PROF
PROF · Transaction Jan 27, 2020 · Filed Aug 26, 2021 · $1,001 to $15,000
PROF · Transaction Jan 14, 2020 · Filed Aug 26, 2021 · $1,001 to $15,000
PROF · Transaction Dec 20, 2019 · Filed Mar 5, 2021 · $1,001 to $15,000
PROF contract awards, year to date.
Public federal awards linked to this ticker.
PROF lobbying filings, year to date.
Registered lobbying filings matched to Profound Medical Corp.